Previous Statements by HALO
» Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript
» Halozyme Therapeutics, Inc. Q4 2008 Earnings Call Transcript
» Halozyme Therapeutics, Inc. Q3 2008 Earnings Call Transcript
Here's how to potentially rake in some fat profits off a number of hot breakout setups.
Halozyme Therapeutics, Omeros and Aralez Pharmaceuticals were among the biotech stock movers in premarket trading on Thursday.
Jim Cramer interviews CEOs from Constellation and Halozyme about their businesses and their stocks' wild ride.